Targeting anti-nephrin antibodies may mitigate recurrence of focal segmental glomerulosclerosis (FSGS) after kidney transplantation, with serial monitoring offering a clinically a ...

Betts, MD, discusses how PTCy and tacrolimus protocols, as well as using younger donors, contributes to higher survival rates ...

A phase 1b/2 randomized controlled trial examined obinutuzumab specifically in patients with active lupus nephritis.

IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, has an estimated incidence of 0.2-5 per 100,000 ...

Rising diagnosed prevalence, substantial unmet medical need and growing clinical development activity across the United States, Europe and Japan.Dublin, July 14, 2026 (GLOBE NEWSWIRE) -- The ...

A 76-year-old man presented with a 3-week history of binocular vertical diplopia.He denied change in vision, pain with eye ...

Learn about teprotumumab for moderate to severe thyroid eye disease, its benefits, risks, as well as evolving treatment ...

Introduction Patients with SLE have an increased risk of infections and infection-related mortality, which may be associated ...

Michael Boyle is an experienced financial professional with more than 10 years working with financial planning, derivatives, equities, fixed income, project management, and analytics. Basis risk ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Congenital heart disease (CHD) is the most common congenital anomaly, with lifelong implications as survival into adulthood ...

Substantial evidence exists that patients with scleroderma have immune dysfunction and autoimmunity, and several studies support the use of immunosuppressive treatment in these patients. Nihtyanova et ...